 |
Ethicon to present obesity treatments at IFSOEthicon, part of Johnson & Johnson Medical Devices Companies (JJMD), will present its innovations in bariatric surgery at the 23rd World Congress of the International Federation for the Surgery of Obesity and Metabolic Diseases (IFSO 2018). More… |
 |
J&J to acquire Israel's Omrix for $465mJohnson & Johnson Inc will acquire Israel's Omrix Biopharmaceuticals Inc for $27 a share, or a total of $465 million, the Globes financial news website said on Monday. Omrix, which makes biosurgical sealants for the prevention of b More… |
